title: Pharmacology of a new low molecular weight dermatan sulphate (Desmin) in healthy volunteers: repeated daily intramuscular administration of 400 mg for a week.
authors.affiliation: Centre for Haemostatic Diseases, Ospedale Maggiore, Parma, Italy.
authors.forename: A G
authors.initials: AG
authors.lastname: Dettori
authors.forename: V
authors.initials: V
authors.lastname: Zamboni
authors.forename: C
authors.initials: C
authors.lastname: Manotti
authors.forename: N
authors.initials: N
authors.lastname: Canova
authors.forename: M
authors.initials: M
authors.lastname: Barbanti
authors.forename: E
authors.initials: E
authors.lastname: Palazzini
mesh_terms: D000328:Adult; D001780:Blood Coagulation Tests; D003871:Dermatan Sulfate / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D065427:Factor Xa Inhibitors; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008970:Molecular Weight; D010314:Partial Thromboplastin Time; D012449:Safety; D013918:Thrombin Time
chemical_list: D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D003871:Dermatan Sulfate